Ischemic heart disease
Conditions
Interventions
None listed
Sponsors
Department of Cardiology, Osaka Police Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Any PCI indication for native coronary lesions satisfying the following criteria 1. PCI indication for any clinical presentation including stable and unstable angina, silent myocardial ischemia, non-ST elevation and ST elevation myocardial infarction. 2. Subject is appropriate to be treated by PCI according to the local practice. 3. Patient is at least 20 years of age. 4. Signed informed consent. 5. The patient understands and accepts clinical follow-up. Angiographic: 1. Patients with angiographically significant stenosis in de novo, native, previously unstinted lesions, which is in operator's opinion appropriate to be treated by PCI. 2.Significant stenosis was defined as 90% or greater stenosis of a major epicardial vessel or proof of functional ischemic test. 3. Patients with angiographically significant stenosis, which is in operator's opinion related to symptoms of angina.
Exclusion criteria
Exclusion criteria: 1. Known hypersensitivity or contraindication to aspirin, clopidogrel, prasugrel, cobalt chromium, platinum chromium, everolimus, sirolimus, or a sensitivity to contrast media, which cannot be adequately pre-medicated 2. Participation in another clinical trial (up to 12 months after index procedure) 3. Patients with a life expectancy of < 2 year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Neointimal coverage grade on coronary angioscopy 3 and 24 months after stent implantation 2. Light property on optical coherence tomography 3 and 24 months after stent implantation | — |
Countries
Japan
Contacts
Public ContactYohei Sotomi
Osaka Police Hospital Department of Cardiology
Outcome results
None listed